Objective To study the clinical features of children with coronavirus disease 2019 (COVID-19) Delta variant infection vaccinated or not vaccinated with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Methods A total of 11 children with COVID-19 Delta variant infection who were vaccinated with inactivated SARS-CoV-2 vaccine and were hospitalized in the designated hospital in Henan Province, China, from November 3 to December 17, 2021 were enrolled as the vaccinated group. Thirty-one children with COVID-19 Delta variant infection who were not vaccinated and were hospitalized during the same period were enrolled as the unvaccinated group. A retrospective analysis was performed on their epidemiological data, clinical features, and laboratory examination results. Results There was no significant difference in gender composition and disease classification between the two groups (P>0.05), and there was also no significant difference in the incidence rates of the clinical symptoms such as cough, expectoration, and fever between the two groups (P>0.05). No significant difference was found between the two groups in leukocyte count, lymphocyte percentage, alanine aminotransferase, and serum creatinine (P>0.05). Compared with the unvaccinated group, the vaccinated group had significantly lower levels of aspartate aminotransferase, lactate dehydrogenase, and creatine kinase-MB (P<0.05). There was no significant difference between the two groups in the proportion of children with elevated C-reactive protein or procalcitonin and the levels of peripheral blood cytokines (P>0.05). The vaccinated group had significantly lower counts of B lymphocytes and total T lymphocytes (CD3+) than the unvaccinated group (P<0.05). Compared with the unvaccinated group, the vaccinated group had a significantly higher positive rate of IgG on admission and at week 2 of the course of disease (P<0.05), as well as a significantly higher Ct value of nucleic acid at weeks 1 and 2 of the course of disease (P<0.05). Conclusions Vaccination with inactivated SARS-CoV-2 vaccine may reduce myocardial injury caused by SARS-CoV-2 Delta variant. For children with SARS-CoV-2 Delta variant infection after the vaccination, more attention should be paid to their immune function.
Key words
Severe acute respiratory syndrome coronavirus 2 /
Delta variant /
Vaccination /
Clinical feature /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 姜心怡, 周文浩. 新型冠状病毒肺炎对儿童神经系统的影响[J]. 中国当代儿科杂志, 2021, 23(5): 530-535. PMID: 34020746. PMCID: PMC8140346. DOI: 10.7499/j.issn.1008-8830.2012115.
2 邱晓燕, 杨慧莹, 颜明明, 等. 新型冠状病毒疫苗研发进展及其潜在不良反应[J]. 中国临床药学杂志, 2021, 30(1): 64-72. DOI: 10.19577/j.1007-4406.2021.01.017.
3 Hodgson SH, Mansatta K, Mallett G, et al. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2[J]. Lancet Infect Dis, 2021, 21(2): e26-e35. PMID: 33125914. PMCID: PMC7837315. DOI: 10.1016/S1473-3099(20)30773-8.
4 Pritchard E, Matthews PC, Stoesser N, et al. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom[J]. Nat Med, 2021, 27(8): 1370-1378. PMID: 34108716. PMCID: PMC8363500. DOI: 10.1038/s41591-021-01410-w.
5 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第八版修订版)[J]. 中华临床感染病杂志, 2021, 14(2): 81-88. DOI: 10.3760/cma.j.issn.1674-2397.2021.02.001.
6 Beyerstedt S, Casaro EB, Rangel éB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(5): 905-919. PMID: 33389262. PMCID: PMC7778857. DOI: 10.1007/s10096-020-04138-6.
7 Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2[J]. Circ Res, 2020, 126(10): 1456-1474. PMID: 32264791. PMCID: PMC7188049. DOI: 10.1161/CIRCRESAHA.120.317015.
8 Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181(2): 271-280.e8. PMID: 32142651. PMCID: PMC7102627. DOI: 10.1016/j.cell.2020.02.052.
9 Bavishi C, Bonow RO, Trivedi V, et al. Special article—acute myocardial injury in patients hospitalized with COVID-19 infection: a review[J]. Prog Cardiovasc Dis, 2020, 63(5): 682-689. PMID: 32512122. PMCID: PMC7274977. DOI: 10.1016/j.pcad.2020.05.013.
10 罗飞, 李树仁, 郝潇, 等. 新型冠状病毒肺炎相关心肌炎发病机制的研究进展[J]. 中国全科医学, 2021, 24(20): 2589-2593. DOI: 10.12114/j.issn.1007-9572.2021.00.524.
11 盛俊峰, 邵兰, 王于林. 11例Delta变异株新型冠状病毒肺炎儿童病例的临床特征分析[J]. 中国当代儿科杂志, 2021, 23(12): 1267-1270. PMID: 34911611. PMCID: PMC8690709. DOI: 10.7499/j.issn.1008-8830.2110043.
12 Zou X, Chen K, Zou J, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection[J]. Front Med, 2020, 14(2): 185-192. PMID: 32170560. PMCID: PMC7088738. DOI: 10.1007/s11684-020-0754-0.
13 Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection[J]. Nat Commun, 2021, 12(1): 2506. PMID: 33947851. PMCID: PMC8096808. DOI: 10.1038/s41467-021-22781-1.
14 高梦圆, 赵泳冰, 刘玺, 等. 新冠肺炎患者肝肾功能损害的临床特征及其与重症及死亡的相关性分析[J]. 第三军医大学学报, 2021, 43(20): 2241-2249. DOI: 10.16016/j.1000-5404.202105042.
15 李旭芳, 赵明奇, 叶家卫, 等. 新型冠状病毒2型感染儿童后外周血淋巴细胞亚群和血清细胞因子水平变化分析[J]. 免疫学杂志, 2021, 37(9): 796-802. DOI: 10.13431/j.cnki.immunol.j.20210112.
PDF(546 KB)
